100 related articles for article (PubMed ID: 15225705)
1. Oxamides as novel NR2B selective NMDA receptor antagonists.
Barta-Szalai G; Borza I; Bozó E; Kiss C; Agai B; Proszenyák A; Keseru GM; Gere A; Kolok S; Galgóczy K; Horváth C; Farkas S; Domány G
Bioorg Med Chem Lett; 2004 Aug; 14(15):3953-6. PubMed ID: 15225705
[TBL] [Abstract][Full Text] [Related]
2. Indole-2-carboxamidines as novel NR2B selective NMDA receptor antagonists.
Borza I; Kolok S; Ignácz-Szendrei G; Greiner I; Tárkányi G; Galgóczy K; Horváth C; Farkas S; Domány G
Bioorg Med Chem Lett; 2005 Dec; 15(24):5439-41. PubMed ID: 16213709
[TBL] [Abstract][Full Text] [Related]
3. Selective NR1/2B N-methyl-D-aspartate receptor antagonists among indole-2-carboxamides and benzimidazole-2-carboxamides.
Borza I; Bozó E; Barta-Szalai G; Kiss C; Tárkányi G; Demeter A; Gáti T; Háda V; Kolok S; Gere A; Fodor L; Nagy J; Galgóczy K; Magdó I; Agai B; Fetter J; Bertha F; Keserü GM; Horváth C; Farkas S; Greiner I; Domány G
J Med Chem; 2007 Mar; 50(5):901-14. PubMed ID: 17290978
[TBL] [Abstract][Full Text] [Related]
4. Benzimidazole-2-carboxamides as novel NR2B selective NMDA receptor antagonists.
Borza I; Kolok S; Gere A; Nagy J; Fodor L; Galgóczy K; Fetter J; Bertha F; Agai B; Horváth C; Farkas S; Domány G
Bioorg Med Chem Lett; 2006 Sep; 16(17):4638-40. PubMed ID: 16782335
[TBL] [Abstract][Full Text] [Related]
5. Development of 3-substituted-1H-indole derivatives as NR2B/NMDA receptor antagonists.
Gitto R; De Luca L; Ferro S; Citraro R; De Sarro G; Costa L; Ciranna L; Chimirri A
Bioorg Med Chem; 2009 Feb; 17(4):1640-7. PubMed ID: 19157884
[TBL] [Abstract][Full Text] [Related]
6. Kynurenic acid amides as novel NR2B selective NMDA receptor antagonists.
Borza I; Kolok S; Galgóczy K; Gere A; Horváth C; Farkas S; Greiner I; Domány G
Bioorg Med Chem Lett; 2007 Jan; 17(2):406-9. PubMed ID: 17074483
[TBL] [Abstract][Full Text] [Related]
7. Discovery of novel and orally active NR2B-selective N-methyl-D-aspartate (NMDA) antagonists, pyridinol derivatives with reduced HERG binding affinity.
Kawai M; Nakamura H; Sakurada I; Shimokawa H; Tanaka H; Matsumizu M; Ando K; Hattori K; Ohta A; Nukui S; Omura A; Kawamura M
Bioorg Med Chem Lett; 2007 Oct; 17(20):5533-6. PubMed ID: 17768047
[TBL] [Abstract][Full Text] [Related]
8. Indole-2-carboxamides as novel NR2B selective NMDA receptor antagonists.
Borza I; Kolok S; Gere A; Agai-Csongor E; Agai B; Tárkányi G; Horváth C; Barta-Szalai G; Bozó E; Kiss C; Bielik A; Nagy J; Farkas S; Domány G
Bioorg Med Chem Lett; 2003 Nov; 13(21):3859-61. PubMed ID: 14552795
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationship study of novel NR2B-selective antagonists with arylamides to avoid reactive metabolites formation.
Kawai M; Sakurada I; Morita A; Iwamuro Y; Ando K; Omura H; Sakakibara S; Masuda T; Koike H; Honma T; Hattori K; Takashima T; Mizuno K; Mizutani M; Kawamura M
Bioorg Med Chem Lett; 2007 Oct; 17(20):5537-42. PubMed ID: 17766107
[TBL] [Abstract][Full Text] [Related]
10. CoMFA, synthesis, and pharmacological evaluation of (E)-3-(2-carboxy-2-arylvinyl)-4,6-dichloro-1H-indole-2-carboxylic acids: 3-[2-(3-aminophenyl)-2-carboxyvinyl]-4,6-dichloro-1H-indole-2-carboxylic acid, a potent selective glycine-site NMDA receptor antagonist.
Baron BM; Cregge RJ; Farr RA; Friedrich D; Gross RS; Harrison BL; Janowick DA; Matthews D; McCloskey TC; Meikrantz S; Nyce PL; Vaz R; Metz WA
J Med Chem; 2005 Feb; 48(4):995-1018. PubMed ID: 15715469
[TBL] [Abstract][Full Text] [Related]
11. Identification of a novel NR2B-selective NMDA receptor antagonist using a virtual screening approach.
Mony L; Triballeau N; Paoletti P; Acher FC; Bertrand HO
Bioorg Med Chem Lett; 2010 Sep; 20(18):5552-8. PubMed ID: 20692832
[TBL] [Abstract][Full Text] [Related]
12. Discovery of (-)-6-[2-[4-(3-fluorophenyl)-4-hydroxy-1-piperidinyl]-1-hydroxyethyl]-3,4-dihydro-2(1H)-quinolinone--a potent NR2B-selective N-methyl D-aspartate (NMDA) antagonist for the treatment of pain.
Kawai M; Ando K; Matsumoto Y; Sakurada I; Hirota M; Nakamura H; Ohta A; Sudo M; Hattori K; Takashima T; Hizue M; Watanabe S; Fujita I; Mizutani M; Kawamura M
Bioorg Med Chem Lett; 2007 Oct; 17(20):5558-62. PubMed ID: 17766106
[TBL] [Abstract][Full Text] [Related]
13. New benzoyl urea derivatives as novel NR2B selective NMDA receptor antagonists.
Borza I; Greiner I; Kolok S; Galgóczy K; Ignácz-Szendrei G; Horváth C; Farkas S; Gáti T; Háda V; Domány G
Pharmazie; 2006 Sep; 61(9):799-800. PubMed ID: 17020160
[TBL] [Abstract][Full Text] [Related]
14. Role of N-methyl-D-aspartate receptors in gastric mucosal blood flow induced by histamine.
Tsai LH; Lee YJ; Wu JY
J Neurosci Res; 2004 Sep; 77(5):730-8. PubMed ID: 15352220
[TBL] [Abstract][Full Text] [Related]
15. Tricyclic indole-2-carboxylic acids: highly in vivo active and selective antagonists for the glycine binding site of the NMDA receptor.
Katayama S; Ae N; Kodo T; Masumoto S; Hourai S; Tamamura C; Tanaka H; Nagata R
J Med Chem; 2003 Feb; 46(5):691-701. PubMed ID: 12593650
[TBL] [Abstract][Full Text] [Related]
16. In vitro characterization of novel NR2B selective NMDA receptor antagonists.
Kiss L; Cheng G; Bednar B; Bednar RA; Bennett PB; Kane SA; McIntyre CJ; McCauley JA; Koblan KS
Neurochem Int; 2005 May; 46(6):453-64. PubMed ID: 15769547
[TBL] [Abstract][Full Text] [Related]
17. NR2B-selective N-methyl-D-aspartate antagonists: synthesis and evaluation of 5-substituted benzimidazoles.
McCauley JA; Theberge CR; Romano JJ; Billings SB; Anderson KD; Claremon DA; Freidinger RM; Bednar RA; Mosser SD; Gaul SL; Connolly TM; Condra CL; Xia M; Cunningham ME; Bednar B; Stump GL; Lynch JJ; Macaulay A; Wafford KA; Koblan KS; Liverton NJ
J Med Chem; 2004 Apr; 47(8):2089-96. PubMed ID: 15056006
[TBL] [Abstract][Full Text] [Related]
18. A novel series of benzimidazole NR2B-selective NMDA receptor antagonists.
Davies DJ; Crowe M; Lucas N; Quinn J; Miller DD; Pritchard S; Grose D; Bettini E; Calcinaghi N; Virginio C; Abberley L; Goldsmith P; Michel AD; Chessell IP; Kew JN; Miller ND; Gunthorpe MJ
Bioorg Med Chem Lett; 2012 Apr; 22(7):2620-3. PubMed ID: 22366657
[TBL] [Abstract][Full Text] [Related]
19. Early chronic blockade of NR2B subunits and transient activation of NMDA receptors modulate LTP in mouse auditory cortex.
Mao Y; Zang S; Zhang J; Sun X
Brain Res; 2006 Feb; 1073-1074():131-8. PubMed ID: 16457785
[TBL] [Abstract][Full Text] [Related]
20. Cyclic benzamidines as orally efficacious NR2B-selective NMDA receptor antagonists.
Nguyen KT; Claiborne CF; McCauley JA; Libby BE; Claremon DA; Bednar RA; Mosser SD; Gaul SL; Connolly TM; Condra CL; Bednar B; Stump GL; Lynch JJ; Koblan KS; Liverton NJ
Bioorg Med Chem Lett; 2007 Jul; 17(14):3997-4000. PubMed ID: 17498948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
